Goldman Sachs Analyst Reinstates Sell Rating on DBV Technologies Amid VP Treatment Risks

On May 28, Goldman Sachs analyst Rajan Sharma reinstated his sell rating on DBV Technologies S.A. (NASDAQ:DBVT) and set the price target at $7.25.

Keep Reading →